Image-guided proton therapy for low- and intermediate-risk prostate cancer: Three-year results of two prospective trials.

被引：0
|
作者：
Henderson, Randal H.
Hoppe, Bradford S.
Nichols, Romaine Charles
Mendenhall, William M.
Marcus, Robert B.
Su, Zhong
Williams, Christopher R.
Li, Zuofeng
Morris, Christopher G.
Mendenhall, Nancy Price
机构：
[1] Univ Florida, Proton Therapy Inst, Jacksonville, FL USA
[2] Univ Florida, Coll Med, Dept Surg, Jacksonville, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 05期
关键词：
D O I：
10.1200/jco.2012.30.5_suppl.152
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
152
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Oncologic outcomes of radiation therapy following active surveillance for low- and intermediate-risk localized prostate cancer.
    Ahmad, Ardalan
    Chua, Melvin
    Murgic, Jure
    Raziee, Hamid Reza
    Hosni, Ali
    De Moraes, Fabio Ynoe
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [22] Toxicity and Quality of Life After Hypofractionated Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer
    Seymour, Z. A.
    Chang, A.
    Roach, M.
    Gottschalk, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S604 - S604
  • [23] Abdominal adiposity, waist circumference, and body mass index in patients with intermediate-risk prostate cancer treated with image-guided radiotherapy
    Zilli, T.
    Nguyen, T.
    Bahary, J.
    Chagnon, M.
    Dufresne, A.
    Taussky, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] Multicenter Trial of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: Survival and Toxicity Endpoints
    Meier, Robert M.
    Bloch, Daniel A.
    Cotrutz, Cristian
    Beckman, Alan C.
    Henning, George T.
    Woodhouse, Shermian A.
    Williamson, Shirnett K.
    Mohideen, Najeeb
    Dombrowski, John J.
    Hong, Robert L.
    Brachman, David G.
    Linson, Patrick W.
    Kaplan, Irving D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (02): : 296 - 303
  • [25] Long-term results of definitive conformal percutaneous radiation in locally confined low- and intermediate-risk prostate cancer
    Deichmueller, C.
    Wegener, G.
    Karstens, J. H.
    Bruns, F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 118 - 118
  • [26] FOCAL CRYOTHERAPY FOR LOW- TO INTERMEDIATE-RISK PROSTATE CANCER: LONG TERM RESULTS AND MATCHED PAIR COMPARISON WITH ACTIVE SURVEILLANCE
    Marra, Giancarlo
    Soeterik, Timo
    Oreggia, Davide
    Pasquali, Caio
    Tourinho-Barbosa, Rafael
    Moschini, Marco
    Filippini, Claudia
    van Melick, Harm H. E.
    van den Bergh, Roderick C. N.
    Gontero, Paolo
    Cathala, Nathalie
    Macek, Petr
    Sanchez-Salas, Rafael
    Cathelineau, Xavier
    JOURNAL OF UROLOGY, 2021, 206 : E817 - E817
  • [27] The results of real-time brachytherapy for the management of low- and intermediate-risk prostate cancer in patients with prostate volumes up to 100 mL
    Dallas, Nicola L.
    Malone, Peter R.
    Jones, Adam
    Doggart, Andrew J.
    McConway, Kevin J.
    Rogers, Paul B.
    BJU INTERNATIONAL, 2012, 110 (03) : 383 - 390
  • [28] Performance of MRI-TRUS-guided fusion biopsy to detect progression on active surveillance for low- and intermediate-risk prostate cancer
    Frye, Thomas P.
    Shakir, Nabeel Ahmad
    Abboud, Steven
    George, Arvin Koruthu
    Merino, Maria J.
    Choyke, Peter L.
    Turkbey, Baris
    Wood, Bradford J.
    Pinto, Peter A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [29] IMAGE-GUIDED (IGRT) HYPOFRACTIONATED RADIOTHERAPY IN LOW-RISK PROSTATE CANCER PATIENTS: RESULTS AND TOXICITY
    Valeriani, Maurizio
    Bonome, Paolo
    Osti, Mattia Falchetto
    De Sanctis, Vitaliana
    Bracci, Stefano
    Bellafiore, Fabiana
    Enrici, Riccardo Maurizi
    ANTICANCER RESEARCH, 2015, 35 (06) : 3701 - 3702
  • [30] Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression
    Kil, Whoon Jong
    Nichols, Romaine C., Jr.
    Hoppe, Bradford S.
    Morris, Christopher G.
    Marcus, Robert B., Jr.
    Mendenhall, William
    Mendenhall, Nancy P.
    Li, Zuofeng
    Costa, Joseph A.
    Williams, Christopher R.
    Henderson, Randal H.
    ACTA ONCOLOGICA, 2013, 52 (03) : 492 - 497
12345